🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Mark J. Levis

Johns Hopkins University

ORCID: 0000-0003-0473-6982
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 13 papers. Top paper: “FLT3 tyrosine kinase inhibitors synergize with BCL-2 inhibition to eliminate FLT3/ITD acute leukemia cells through BIM activation”.

FLT3 tyrosine kinase inhibitors synergize with BCL-2 inhibition to eliminate FLT3/ITD acute leukemia cells through BIM activation

Signal Transduction and Targeted Therapy(2021)10.1038/s41392-021-00578-4
N/A
0.704DataRank · unranked
108 citations

Li Li, Bao Nguyen, Jaesung Seo, Min Wu, Tessa Seale +5 more

An Update on FLT3 in Acute Myeloid Leukemia: Pathophysiology and Therapeutic Landscape

Current Oncology Reports(2023)10.1007/s11912-023-01389-2
N/A
0.553DataRank · unranked
39 citations

Mark J. Levis, Rebecca Bystrom

A Method for Overcoming Plasma Protein Inhibition of Tyrosine Kinase Inhibitors

Blood Cancer Discovery(2021)10.1158/2643-3230.bcd-20-0119
N/A
0.312DataRank · unranked
7 citations

Bao Nguyen, Li Li, Tomoyasu Higashimoto, Mark J. Levis, Jun O. Liu +2 more

Single-cell DNA sequencing reveals complex mechanisms of resistance to quizartinib

Blood Advances(2021)10.1182/bloodadvances.2020003398
N/A
0DataRank · unranked
40 citations

Lisa H.F. McGary, Tanya Kumar, Hunter Jackson, Jose Jacob, Robert Durruthy-Durruthy +5 more

Arsenic trioxide dose capping to decrease toxicity in the treatment of acute promyelocytic leukemia

Journal of Oncology Pharmacy Practice(2021)10.1177/10781552211024727
N/A
0DataRank · unranked
12 citations

Bryan C. Hambley, Erin Hickey, Sarah Kashanian, Andrew Li, Maria R. Baer +11 more

Nonmyeloablative Allogeneic Transplantation With Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia With IDH Mutations: A Single Center Experience

Clinical Lymphoma Myeloma & Leukemia(2021)10.1016/j.clml.2021.09.022
N/A
0DataRank · unranked
6 citations

Matthew L. Smith, Hua‐Ling Tsai, Ravi Varadhan, Amy E. DeZern, W. Brian Dalton +23 more

The K666N mutation in SF3B1 is associated with increased progression of MDS and distinct RNA splicing

Blood Advances(2020)10.1182/bloodadvances.2019001127
N/A
0DataRank · unranked
60 citations

Eric Helmenstine, Lisa Pieterse, Bing Li, Christopher D. Gocke, Joshua Donaldson +8 more

Post-Transplantation Cyclophosphamide-Based Graft- versus-Host Disease Prophylaxis with Nonmyeloablative Conditioning for Blood or Marrow Transplantation for Myelofibrosis

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.02.004
N/A
0DataRank · unranked
27 citations

Hua‐Ling Tsai, Amy E. DeZern, Lukasz P. Gondek, Hany Elmariah, Javier Bolaños‐Meade +22 more

Allogeneic Blood or Marrow Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Acute Lymphoblastic Leukemia in Patients Age ≥55 Years

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.12.018
N/A
0DataRank · unranked
7 citations

Madison Reed, Hua‐Ling Tsai, Alexander J. Ambinder, Tania Jain, Amy E. DeZern +25 more

Data from A Method for Overcoming Plasma Protein Inhibition of Tyrosine Kinase Inhibitors

(2023)10.1158/2643-3230.c.6550254.v1
N/A
0DataRank · unranked
0 citations

Bao N. Nguyen, Li Li, Tomoyasu Higashimoto, Mark J. Levis, Jun O. Liu +2 more

Targeting rapid TKI ‐induced AXL upregulation overcomes adaptive ERK reactivation and exerts antileukemic effects in FLT3 / ITD acute myeloid leukemia

Molecular Oncology(2024)10.1002/1878-0261.13749
N/A
0DataRank · unranked
4 citations

Li Li, J. Kyle Bruner, Melody Chou, Bao Nguyen, Jaesung Seo +5 more

Efficacy and safety of blinatumomab for CD19 + acute leukemias in patients historically excluded from clinical trials due to comorbidities

Leukemia Research(2025)10.1016/j.leukres.2025.108098
N/A
0DataRank · unranked
1 citations

Daniel Li, Hua‐Ling Tsai, Gabriel Ghiaur, B. Douglas Smith, Mark J. Levis +10 more

Allogeneic transplantation for Ph+ acute lymphoblastic leukemia with posttransplantation cyclophosphamide

Blood Advances(2020)10.1182/bloodadvances.2020002945
N/A
0DataRank · unranked
31 citations

Leo Luznik, Hua-Ling Tsai, Philip Imus, Amy E. DeZern, Keith W. Pratz +21 more